The Latest Cardiac and Vascular News
SAN CLEMENTE, Calif., Oct. 26, 2017 /PRNewswire/ — Rox Medical Inc., a privately held medical device company pioneering an innovative interventional vascular therapy for uncontrolled hypertension, announced the publication of 12-month outcomes of the ROX CONTROL HTN study in the prestigious journal, Hypertension. CONTROL HTN is a multi-center randomized controlled trial that […]
SAN CARLOS, Calif.–(BUSINESS WIRE)–BioTrace Medical, Inc., today announced the company’s key activities at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 meeting, which will take place October 29 – November 2 at the Colorado Convention Center in Denver. The company’s Tempo® Temporary Pacing Lead will be featured in a breakfast symposium titled: “The […]
MARLBOROUGH, Mass., Oct. 26, 2017 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) generated sales of $2.222 billion during the third quarter ended September 30, 2017. This represents growth of 5.6 percent on a reported basis and 5.7 percent on an operational basis (excludes the impact of changes in foreign currency exchange rates), all compared to the […]
NEWARK, Del., Oct. 26, 2017 /PRNewswire/ — More than 10 million people from 6,600 companies participated in the survey process for the World’s Best Workplaces list, sharing their perspectives on their work environment. And for the sixth consecutive year, W. L. Gore & Associates is among just 25 companies to earn a spot on the […]
HOUSTON–(BUSINESS WIRE)–October 26, 2017– CorInnova Inc., an emerging medical device company developing novel technology for the treatment of Heart Failure, announced today three milestone events: (1) the Company has received notice of allowance of a seminal patent to protect its intellectual property associated with the world’s first minimally invasively-delivered soft robotic […]
MURRAY HILL, N.J.–(BUSINESS WIRE)– C.R. Bard (NYSE: BCR) today reported 2017 third quarter financial results. The company has included supplemental financial data on its website related to this earnings release. Third quarter 2017 net sales were $989.8 million, an increase of 5 percent over the prior-year period on an as-reported basis. Excluding the […]
ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (NASDAQ: CSII): Conference Call Scheduled for Today, October 25, 2017, at 3:45 PM CT (4:45 PM ET) Revenues of $49.7 million were flat versus first quarter last year Gross margin increased to 81.5% from 81.0% in the prior-year period Net loss was $(2.0) […]
SAN ANTONIO, Oct. 26, 2017 /PRNewswire/ — CeloNova BioSciences, a global medical device company that offers a family of innovative products based upon its proprietary Polyzene™-F nanocoating technology, today announced that the U.S. Federal Drug Administration (FDA) approved expansion of CeloNova’s ongoing clinical trial of its proprietary COBRA PzF™ NanoCoated Coronary […]
A new study has found females and minorities have a greater risk of restenosis and subsequent MACE than “white” men after receiving everolimus-eluting stent implantation. The Study Setup A cohort study that pulled thousands of patients from both the PLATINUM Diversity and PROMUS Element Plus Post-Approval looked at groups of men, women […]
SAN FRANCISCO–(BUSINESS WIRE)–Bay Labs, a medical technology company at the forefront of applying artificial intelligence to cardiovascular imaging, today announced that Emeritus Professor of Medicine (Cardiology) at Emory University School of Medicine and the company’s Chief Medical Officer Randolph P. Martin, M.D. FACC, FASE, has been invited to be a […]
